PCR Seminar on TAVI 2025 Successfully Concludes in New Delhi

New Delhi: The first PCR Seminar on Transcatheter Aortic Valve Implantation (TAVI) was successfully held from December 13 to 14, 2025, at the Andaz Hotel in New Delhi, under the leadership of Dr. Viveka Kumar (India). It brought together leading experts, clinicians, and industry stakeholders to discuss the latest advancements in structural heart interventions.
The two-day academic program saw participation from 270 registered attendees, including 21 distinguished faculty members, 150 delegates, and 100 industry partners, making it a highly engaging and academically enriching platform for scientific exchange.
The seminar was designed to foster high-quality scientific discussions, share global best practices, and explore recent innovations in Transcatheter Aortic Valve Implantation (TAVI). Through expert-led sessions, case-based discussions, and interactive deliberations, the program made a significant contribution to advancing clinical knowledge and improving patient care.
Speaking on the success of the program, Dr. Viveka Kumar said that the seminar has proven to be a significant milestone in promoting continuing medical education and collaborative learning in the field of structural heart disease in India.
Continuing this momentum, the PCR educational program in India is scheduled to be held again on October 10 and 11, 2026, reaffirming PCR’s commitment to advancing cardiovascular education and excellence.